Investing
Opening Bell Analyst Calls Briefing for Tuesday, November 1, 2022
Published:
This report was sent to Briefing.com subscribers earlier today.
Downgrades:
> DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $72
> Inovio Pharma (INO) downgraded to Underperform from Neutral at BofA Securities; tgt $2
> Instil Bio (TIL) downgraded to Hold from Buy at Truist; tgt lowered to $6
> Skechers USA (SKX) downgraded to Hold from Buy at Argus
> Varonis Systems (VRNS) downgraded to Hold from Buy at Craig Hallum
> Ventas (VTR) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $46
> Welltower (WELL) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $70
Others:
> Cairn Energy (CRNCY) resumed with an Equal Weight at Barclays
Research calls posted earlier this morning are available here and here.
“The Next NVIDIA” Could Change Your Life
If you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
Click here to download your FREE copy.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
